Welcome to our dedicated page for Dswiss news (Ticker: DQWS), a resource for investors and traders seeking the latest updates and insights on Dswiss stock.
News and disclosures about DSWISS Inc (DQWS) focus on its activities as a biotech-nutraceutical, medical consumables, and beauty supplies company operating within the Manufacturing sector. The company’s communications highlight both its core OEM/ODM private label manufacturing services for nutraceutical and skincare products and its strategic initiatives in related health and hygiene technologies.
One notable news item describes a global partnership between DSWISS and Japan-listed RECOMM Co., Ltd for an exclusive arrangement involving the RESPR air and surface purifier and sterilizer in Malaysia. This collaboration is presented as aligning DSWISS’s sales and marketing capabilities with RECOMM’s multi-national business scale, and it underscores DSWISS’s interest in products positioned for use during the COVID-19 pandemic. The RESPR device is described as a "COVID-19 killer" purifier and sterilizer that uses NCC technology to generate natural oxidants such as hydrogen peroxide, with certified results in reducing 99.9% of the SARS CoV-2 virus.
On this news page, readers can follow company announcements about partnerships, product-related developments, and other material updates that DSWISS chooses to publicize. Regulatory disclosures, such as SEC filings referenced in news coverage, may also be reflected when they relate to governance changes or other significant corporate events.
Investors, customers, and observers who track DQWS can use this page to review how DSWISS communicates its role in biotech-nutraceuticals, medical consumables, skincare, and air and surface sterilization collaborations. Returning to this page allows users to see how the company’s narrative and strategic focus evolve through formal announcements and third-party news coverage.
DSwiss, Inc (OTCPINK:DQWS) announced a global partnership with Japan's RECOMM Co., Ltd for exclusive distribution of the RESPR air and surface purifier in Malaysia. This partnership combines DSwiss's marketing expertise with RECOMM's multinational scale, aiming for long-term growth amidst the COVID-19 pandemic. The RESPR device, using NCC technology, effectively reduces 99.9% of the SARS CoV-2 virus, positioning it as a significant solution in response to ongoing public health challenges.